FDA Inspection 1122446 — SpecGx, LLC

SpecGx, LLC — FEI 3005275960

The FDA completed an inspection of SpecGx, LLC on Mar 16, 2020 in Webster Groves, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 16, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Webster Groves, MO (United States)

Additional details

Risk Evaluation and Mitigation Strategies (REMS)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.